Bridging the gaps between cancer genomics, computational solutions and healthcare delivery

IF 1 Q4 PHARMACOLOGY & PHARMACY

Expert Review of Precision Medicine and Drug Development Pub Date : 2020-10-10 DOI:10.1080/23808993.2020.1825937

S. Cooke, P. Beer

引用次数: 0

Abstract

For learnings from academic research to impact health outcomes, they must be embedded into routine clinical practice. Research innovations such as the human genome project, next-generation sequenci...

查看原文本刊更多论文

弥合癌症基因组学、计算解决方案和医疗保健之间的差距

为了从学术研究中获得影响健康结果的经验教训，必须将其纳入常规临床实践中。研究创新，如人类基因组计划，下一代测序。。。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Review of Precision Medicine and Drug Development PHARMACOLOGY & PHARMACY-

CiteScore

2.30

自引率

0.00%

发文量

期刊介绍： Expert Review of Precision Medicine and Drug Development publishes primarily review articles covering the development and clinical application of medicine to be used in a personalized therapy setting; in addition, the journal also publishes original research and commentary-style articles. In an era where medicine is recognizing that a one-size-fits-all approach is not always appropriate, it has become necessary to identify patients responsive to treatments and treat patient populations using a tailored approach. Areas covered include: Development and application of drugs targeted to specific genotypes and populations, as well as advanced diagnostic technologies and significant biomarkers that aid in this. Clinical trials and case studies within personalized therapy and drug development. Screening, prediction and prevention of disease, prediction of adverse events, treatment monitoring, effects of metabolomics and microbiomics on treatment. Secondary population research, genome-wide association studies, disease–gene association studies, personal genome technologies. Ethical and cost–benefit issues, the impact to healthcare and business infrastructure, and regulatory issues.